ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Sequestration Delayed For Two Months While Congress Debates Debt and Budgets

January 4, 2013

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

September 3, 1976

In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding

June 24, 1994

Consensus Conference On Receptors Planned

June 22, 1979

ACS: Decline in Death Rates Saved Over 1.3 Million Lives

January 10, 2014

Cancer Panel: Lack Of Genetic Basis For Race Presents Dilemma For Studies; Data Collection Must Include Socioeconomic Measures, Report To Clinton Says

March 20, 1998